BioSil Improving your Life Starting Today

BioSil Improving your Life

BioSil®: improving Your Life
– Starting Today

The condition of your hair, skin, and nails depends on three proteins:
Collagen ‘plumps’ your skin, removing fine lines and wrinkles, and preventing them from forming. In addition, collagen is essential for strong, healthy bones and joints.

Keratin is the protein that’s packed into your hair shaft. It gives your hair thickness, body, strength, and elasticity. Plus, keratin gives your nails strength and clarity.

Elastin gives your skin its ability to stretch and ‘bounce back’ (elasticity) preventing fine lines and wrinkles. With age collagen, keratin and elastin decline. BioSil Hair Skin Nails with clinically proven ch-OSA®, is specifically formulated to help nourish your body’s 3 beauty proteins and restore them to more youthful levels.

Your Skin
By generating collagen in your skin, BioSil Hair Skin Nails decreases fine lines and wrinkles, and increases skin elasticity. Users also report it adds a radiant quality to their skin.
Published Clinical Trial Results: Barel et al 2005

Your Hair
BioSil Hair Skin Nails helps your hair grow thicker and stronger. The ch-OSA in BioSil has been clinically shown to significantly increase the diameter of each hair shaft – adding fullness and body to your hair. In addition, BioSil Hair Skin Nails helps make your hair stronger, more elastic, and more break resistant.
Published Clinical Trial Results: Wickett et al 2007

Your Nails
BioSil has been clinically shown to strengthen your nails, making them more break resistant.
The BioSil nail phenomenon has given birth to a new expression: ‘Unbreakable Beauty.’
Published Clinical Trial Results: Barel et al 2005

Your Bones
In a clinical trial women were divided into two groups: BioSil and Placebo. The BioSil group took ch-OSA, 1000 mg/day of calcium, and 800 IU/day vitamin D. The Placebo group took only the calcium and vitamin D. Bone collagen synthesis was increased in the BioSil group compared to placebo. Placebo subjects lost 1.22% in bone mineral density (BMD) at the hip region whereas the BioSil subjects (6 drops ch-OSA/day) gained 0.78%. That’s a difference of 2.00%, or 200% higher than the threshold of clinical relevance. Published Clinical Trial Results: Spector et al 2008